The activities of the pan-Canadian Pharmaceutical Alliance are ongoing now and continuing, and what the bill references is the development of advice that would support a conversation among provinces, territories, indigenous peoples and other partners and stakeholders about where to go next and what might happen in the future development of national pharmacare.
It's distinguishing between the actual activity that's occurring now—that's the pCPA you're referring to, which is not being terminated in any way—and the development of advice to support a conversation about the future of pharmacare.